Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration

Rao SR. et al, (2020), The Journal of Molecular Diagnostics, 22, 652 - 669

Genomic copy number predicts oesophageal cancer years before transformation

Killcoyne S. et al, (2020)

The evolutionary history of 2,658 cancers.

Gerstung M. et al, (2020), Nature, 578, 122 - 128

Inferring structural variant cancer cell fraction.

Cmero M. et al, (2020), Nature communications, 11

Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.

Rubanova Y. et al, (2020), Nature communications, 11

Pan-cancer analysis of whole genomes

(2020), Nature, 578, 82 - 93

A community effort to create standards for evaluating tumor subclonal reconstruction

Salcedo A. et al, (2020), Nature Biotechnology, 38, 97 - 107

Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma

Noorani A. et al, (2020), Nature Genetics, 52, 74 - 83

Embryonal precursors of Wilms tumor

Coorens THH. et al, (2019), Science, 366, 1247 - 1251

Genomic landscape and chronological reconstruction of driver events in multiple myeloma

Maura F. et al, (2019), Nature Communications, 10

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers.

Hancock BA. et al, (2019), Breast Cancer Res, 21

Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis

Petljak M. et al, (2019), Cell, 176, 1282 - 1294.e20

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nik-Zainal S. et al, (2019), Nature, 566

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.

Cheng J. et al, (2019), Nat Commun, 10

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.

Cheng J. et al, (2018), Nat Commun, 9

Genomic patterns of progression in smoldering multiple myeloma

Bolli N. et al, (2018), Nature Communications, 9

Neutral tumor evolution?

Tarabichi M. et al, (2018), Nat Genet, 50, 1630 - 1633

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

Höglander EK. et al, (2018), Genome Med, 10

A unified haplotype-based method for accurate and comprehensive variant calling

Cooke DP. et al, (2018)

Classification and Personalized Prognosis in Myeloproliferative Neoplasms.

Grinfeld J. et al, (2018), N Engl J Med, 379, 1416 - 1430

Load More

1
2
3
4
5
6

Include forthcoming?